Sort
15,273 grants matching “antimicrobial resistance”
Direct-from-specimen identification of pathogens common in endocarditis
$1,049,999Alon Singer · Helixbind, Inc. · R44 · FY2025 · AI
Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea
$1,049,943Laurene Wang · Aimmax Therapeutics, Inc. · R44 · FY2025 · AI
Exploiting Riboswitch Sensors to Reveal Antibiotics Uptake and Retention in Gram Negative Bacteria
$1,047,570Ronald R Breaker · Yale University · R01 · FY2022 · AI
Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens
$1,047,323Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2022 · AI
Sexually Transmitted Infections Clinical Trial Group: Clinical Study of Point-of-Care Diagnostics
$1,046,425Jeffrey Klausner · Social And Scientific Systems, Inc. · N01 · FY2019 · AI
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections
$1,042,376Michael E Selsted · University Of Southern California · R01 · FY2017 · AI
Host-bacterial interactions determining the spectrum of Mtb transmission
$1,041,944Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Chemistry Core
$1,040,570Timothy S Bugni · University Of Wisconsin-Madison · U19 · FY2019 · AI
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
$1,040,468David J. Margolis · University Of Pennsylvania · U01 · FY2021 · AR
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
$1,036,121Victor Nizet · University Of California, San Diego · R01 · FY2011 · AI
Chemistry Core
$1,035,799Timothy S Bugni · University Of Wisconsin-Madison · U19 · FY2023 · AI
Identifying novel anti-infectives by high through-put screening in whole animals
$1,035,268Frederick M Ausubel · Massachusetts General Hospital · R01 · FY2012 · AI
Bacterial Functions Involved in Cell Growth Control
$1,034,389Susan Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Development of novel proteins synthesis inhibitors for MDR tuberculosis
$1,034,057Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2010 · AI
Mechanisms of Chromosome Maintenance in Bacteria
$1,032,156Dhruba K Chattoraj · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Diagnostics for Rapid Treatment and Control of Multidrug-Resistance in Healthcare
$1,031,385Lance Robert Peterson · Endeavor Health Clinical Operations · R56 · FY2010 · AI
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
$1,029,338David J. Margolis · University Of Pennsylvania · U01 · FY2022 · AR
Integrated Data and Simulation Environment in Public Health Informatics
$1,028,748Matthew Samore · University Of Utah · P01 · FY2008 · CD
Exploration, conservation, & development of marine biodiversity in Fiji and the S
$1,028,666Mark E Hay · Georgia Institute Of Technology · U19 · FY2014 · TW
Novel polymeric materials with improved durability in the oral environment: tailoring responses to host and bacterial enzymes with anti-proteolytic and ecology-based antimicrobial approaches.
$1,028,106Carmem S. Pfeifer · Oregon Health & Science University · R35 · FY2025 · DE
An automated culture-free system for the identification of bloodstream infections direct from blood
$1,027,841Alon Singer · Helixbind, Inc. · R44 · FY2025 · AI
Identification of novel MDR antimicrobials from human microbiome symbioses
$1,027,236Nasia Safdar · University Of Wisconsin-Madison · U19 · FY2021 · AI
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
$1,027,000Victor Nizet · University Of California, San Diego · R01 · FY2023 · AI
Protective film-forming disinfectant based on chitosan/water/ethanol tertiary solutions
$1,025,000David John Meisinger · Vrm Labs Inc · R44 · FY2024 · AI
Protective film-forming disinfectant based on chitosan/water/ethanol tertiary solutions
$1,025,000David John Meisinger · Vrm Labs Inc · R44 · FY2025 · AI